Premium
Nexentis Techgnologies Inc (NXTS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company’s pipeline includes MITOLINE, an algorithm used to perform multiple seq... Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company’s pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.695 | -15.9770114943 | 4.35 | 4.57 | 3.31 | 99171 | 4.20157886 | CS |
| 4 | -1.505 | -29.1666666667 | 5.16 | 23.8 | 3.31 | 4371487 | 11.41553174 | CS |
| 12 | -0.685 | -15.7834101382 | 4.34 | 23.8 | 3.31 | 1403260 | 11.31165989 | CS |
| 26 | 2.055 | 128.4375 | 1.6 | 23.8 | 0.5532 | 1098794 | 7.39768339 | CS |
| 52 | 3.405 | 1362 | 0.25 | 23.8 | 0.135 | 997407 | 4.53940797 | CS |
| 156 | 2.105 | 135.806451613 | 1.55 | 23.8 | 0.135 | 4688275 | 1.33695193 | CS |
| 260 | 2.105 | 135.806451613 | 1.55 | 23.8 | 0.135 | 4688275 | 1.33695193 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
